Want to see HK:2293 full AI Analyst Report?
2293 Stock Chart & Stats
HK$0.50
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.50
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.36 - HK$0.59
Previous CloseN/A
Volume8.00K
Average Volume (3M)19.31K
Market Cap
HK$148.91M
Enterprise ValueHK$191.94M
Total Cash (Recent Filing)HK$39.20M
Total Debt (Recent Filing)HK$60.94M
Price to Earnings (P/E)8.9
Beta0.17
Next Earnings
Sep 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield10.81%
Share Statistics
EPS (TTM)0.04
Shares Outstanding402,460,000
10 Day Avg. Volume2,658
30 Day Avg. Volume19,312
Financial Highlights & Ratios
PEG Ratio-0.26
Price to Book (P/B)0.87
Price to Sales (P/S)2.69
P/FCF Ratio5.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetModest debt-to-equity (≈0.27–0.33) and a conservatively positioned balance sheet provide a durable financial cushion. This reduces refinancing and solvency risk, supports operations through cycles, and leaves capacity to fund opportunistic investments or sustain distributions over the medium term.
High Operating MarginsSustained gross (~42%) and net (~24%) margins reflect pricing power and an efficient cost base in its staffing model. These margins generate persistent internal cash for reinvestment or payouts, underpinning resilience even if top-line growth softens over the next several months.
Positive Cash GenerationSteady operating and free cash flow in the mid‑30M range provides durable funding for capital needs, dividends, and working capital. Reliable positive FCF reduces reliance on external financing and supports strategic flexibility over a 2–6 month horizon and beyond.
Bears Say
Declining Revenue TrendA multi-year top-line decline culminating in ~-13% in 2025 signals loss of scale and demand headwinds. Persistent revenue contraction reduces margin leverage, limits reinvestment capacity, and raises risk to earnings and dividend sustainability if the trend continues over coming quarters.
ROE And Margin DeteriorationFalling ROE (~7.6%) and compressing margins indicate weakening returns on shareholder capital and reduced operational efficiency versus earlier periods. This structural erosion of profitability can constrain management's ability to fund growth or maintain shareholder returns over the medium term.
Weaker Cash Conversion & TransparencyWeaker recent cash conversion and missing coverage ratios reduce confidence in earnings quality. If profits do not reliably translate into cash, the company may face limits on capital allocation, dividend coverage, or require balance-sheet use, creating a structural operational risk.
Bamboos Health Care Holdings Ltd News
2293 FAQ
What was Bamboos Health Care Holdings Ltd’s price range in the past 12 months?
Bamboos Health Care Holdings Ltd lowest stock price was HK$0.36 and its highest was HK$0.59 in the past 12 months.
What is Bamboos Health Care Holdings Ltd’s market cap?
Bamboos Health Care Holdings Ltd’s market cap is HK$148.91M.
When is Bamboos Health Care Holdings Ltd’s upcoming earnings report date?
Bamboos Health Care Holdings Ltd’s upcoming earnings report date is Sep 30, 2026 which is in 56 days.
How were Bamboos Health Care Holdings Ltd’s earnings last quarter?
Bamboos Health Care Holdings Ltd released its earnings results on Feb 25, 2026. The company reported HK$0.023 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.023.
Is Bamboos Health Care Holdings Ltd overvalued?
According to Wall Street analysts Bamboos Health Care Holdings Ltd’s price is currently Overvalued.
Does Bamboos Health Care Holdings Ltd pay dividends?
Bamboos Health Care Holdings Ltd pays a Semiannually dividend of HK$0.015 which represents an annual dividend yield of 10.81%. See more information on Bamboos Health Care Holdings Ltd dividends here
What is Bamboos Health Care Holdings Ltd’s EPS estimate?
Bamboos Health Care Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bamboos Health Care Holdings Ltd have?
Bamboos Health Care Holdings Ltd has 402,460,000 shares outstanding.
What happened to Bamboos Health Care Holdings Ltd’s price movement after its last earnings report?
Bamboos Health Care Holdings Ltd reported an EPS of HK$0.023 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2%.
Which hedge fund is a major shareholder of Bamboos Health Care Holdings Ltd?
Currently, no hedge funds are holding shares in HK:2293
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bamboos Health Care Holdings Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.09%
12-Months-Change
Fundamentals
Return on Equity
10.81%
Trailing 12-Months
Asset Growth
6.87%
Trailing 12-Months
Company Description
Bamboos Health Care Holdings Ltd
Bamboos Health Care Holdings Limited functions as an investment holding entity primarily dedicated to furnishing healthcare workforce solutions throughout Hong Kong. Its extensive array of services includes vital support for medical facilities and tailored private nursing provisions. Beyond these core offerings, the company also engages in providing marketing and consultancy, fostering the advancement and deployment of technological applications, and operating its own chain of aesthetic clinics. Catering to a diverse clientele, Bamboos Health Care assists both private individuals and organizational clients such as hospitals, social welfare organizations, and various clinics. Founded in 2009, the firm's main offices are located in Tsim Sha Tsui, Hong Kong.
Technical Analysis
Raily Aesthetic Medicine International Holdings Limited
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―
UMP Healthcare Holdings Limited
―
Medicskin Holdings Ltd.
―